Cargando…

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway

Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jie, Li, Juan, Li, Pingping, Wang, Yaochun, Liang, Zheyong, Jiang, Yina, Li, Jing, Feng, Chen, Wang, Ruiqi, Chen, He, Zhou, Can, Zhang, Jianmin, Yang, Jin, Liu, Peijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294562/ https://www.ncbi.nlm.nih.gov/pubmed/28169360 http://dx.doi.org/10.1038/srep42125

Ejemplares similares

CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells
por: Mao, Xiaona, et al.
Publicado: (2017)

DLG5 suppresses breast cancer stem cell‐like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression
por: Liu, Jie, et al.
Publicado: (2018)

High expression of DLG3 is associated with decreased survival from breast cancer
por: Liu, Jie, et al.
Publicado: (2019)

Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
por: Li, Juan, et al.
Publicado: (2017)

Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
por: Liu, Jie, et al.
Publicado: (2020)

Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
por: Liang, Zheyong, et al.
Publicado: (2017)

DLG5 in Cell Polarity Maintenance and Cancer Development
por: Liu, Jie, et al.
Publicado: (2014)

CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status
por: Feng, Xuefei, et al.
Publicado: (2019)

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2017)

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2022)

CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis
por: Wang, Bo, et al.
Publicado: (2023)

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Li, Pingping, et al.
Publicado: (2020)

Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β‐catenin signalling to restore tamoxifen sensitivity
por: Li, Pingping, et al.
Publicado: (2018)

Characterizing the Binding Sites for GK Domain of DLG1 and DLG4 via Molecular Dynamics Simulation
por: Li, Hongwei, et al.
Publicado: (2020)

DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2
por: Kwan, Julian, et al.
Publicado: (2016)

DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells
por: Song, Shaoran, et al.
Publicado: (2022)

Suppressor of Ty 16 promotes lung cancer malignancy and is negatively regulated by miR‐1227‐5p
por: Yang, Lu, et al.
Publicado: (2020)

Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion
por: Li, Juan, et al.
Publicado: (2014)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
por: Xin, Huixian, et al.
Publicado: (2022)

Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma
por: Rong, Jun, et al.
Publicado: (2018)

Dlg5 maintains apical polarity by promoting membrane localization of Crumbs during Drosophila oogenesis
por: Luo, Jun, et al.
Publicado: (2016)

Hippo pathway inhibition promotes metabolic adaptability and antioxidant response in myoblasts
por: Liu, Qi, et al.
Publicado: (2023)

Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
por: Liu, Jie, et al.
Publicado: (2022)

The SF3B1(R625H) mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1
por: Guo, Jing, et al.
Publicado: (2022)

Loss of Dlg-1 in the Mouse Lens Impairs Fibroblast Growth Factor Receptor Signaling
por: Lee, SungKyoung, et al.
Publicado: (2014)

NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
por: Wang, Lijun, et al.
Publicado: (2021)

Circ-DLG 1 promotes the proliferation of esophageal squamous cell carcinoma [Erratum]
Publicado: (2018)

Dlg1 Knockout Inhibits Microglial Activation and Alleviates Lipopolysaccharide-Induced Depression-Like Behavior in Mice
por: Peng, Zhixin, et al.
Publicado: (2021)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019)

Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules
por: He, Tao, et al.
Publicado: (2019)

RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway
por: Ye, Fei, et al.
Publicado: (2023)

Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
por: Yang, Jiao, et al.
Publicado: (2019)

TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
por: Yang, Lu, et al.
Publicado: (2021)

DLG2 variants in patients with pubertal disorders
por: Jee, Youn Hee, et al.
Publicado: (2020)

Functional aspects of primary cilium in signaling, assembly and microenvironment in cancer
por: Wang, Bo, et al.
Publicado: (2020)

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma
por: Keane, Simon, et al.
Publicado: (2021)

FGF6 promotes cardiac repair after myocardial infarction by inhibiting the Hippo pathway
por: Hu, Zhicheng, et al.
Publicado: (2022)

A closer look at the synapse: dlg1[4K] enables cell-specific visualization of PSD-95/DLG1
por: Hendricks, Emily L., et al.
Publicado: (2023)

Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells
por: Li, Hongxia, et al.
Publicado: (2022)

Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression
por: Liu, Bingbing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8nn7vds3202tlgup721uf7ct3